Zerina Jasarevic

704 total citations
19 papers, 529 citations indexed

About

Zerina Jasarevic is a scholar working on Cancer Research, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Zerina Jasarevic has authored 19 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 6 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Zerina Jasarevic's work include Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (6 papers) and Breast Implant and Reconstruction (4 papers). Zerina Jasarevic is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Breast Lesions and Carcinomas (6 papers) and Breast Implant and Reconstruction (4 papers). Zerina Jasarevic collaborates with scholars based in Austria, Switzerland and Germany. Zerina Jasarevic's co-authors include Felix Offner, A. Haid, Michael Knauer, Roswitha Köberle-Wührer, H Fritzsche, Herbert Tilg, Barbara Enrich, Christian J. Wiedermann, Arthur Kaser and Stefan Dunzendorfer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Zerina Jasarevic

19 papers receiving 521 citations

Peers

Zerina Jasarevic

SURGE

ONCOL

PFM

IMMUN

Jasmine Wong United States

Guinebretière Jm France

Charles R. Boice United States

H. Jouhadi Morocco

Alejandro Andicoechea Spain

Jula Veerapong United States

William R. Fair United States

Jathine Wong United States

T. Rinda Soong United States

Robert Hüneburg Germany

Jasmine Wong United States

Zerina Jasarevic

319 ×1.4

149 ×0.9

SURGE

194 ×1.2

ONCOL

243 ×1.9

PFM

52 ×0.4

IMMUN

Citations per year, relative to Zerina Jasarevic Zerina Jasarevic (= 1×) peers Jasmine Wong

Countries citing papers authored by Zerina Jasarevic

Since Specialization

Citations

This map shows the geographic impact of Zerina Jasarevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zerina Jasarevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zerina Jasarevic more than expected).

Fields of papers citing papers by Zerina Jasarevic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zerina Jasarevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zerina Jasarevic. The network helps show where Zerina Jasarevic may publish in the future.

Co-authorship network of co-authors of Zerina Jasarevic

This figure shows the co-authorship network connecting the top 25 collaborators of Zerina Jasarevic. A scholar is included among the top collaborators of Zerina Jasarevic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zerina Jasarevic. Zerina Jasarevic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Jasarevic, Zerina, et al.. (2023). Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(6). 873–878. 1 indexed citations

Jahn, Stephan, Oleksiy Tsybrovskyy, Ruth Helfgott, et al.. (2020). Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests. British Journal of Cancer. 122(12). 1744–1746. 11 indexed citations

Savic, Spasenija, Sabina Berezowska, Serenella Eppenberger‐Castori, et al.. (2019). PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 475(1). 67–76. 14 indexed citations

Haid, A., et al.. (2017). Does BMI affect the detection of sentinel lymph nodes with indocyanine green in early breast cancer patients?. European surgery. Supplement/European surgery. 49(4). 165–170. 4 indexed citations

Spitzmüller, Andreas, et al.. (2017). MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer. PLoS ONE. 12(8). e0183458–e0183458. 12 indexed citations

Haid, A., et al.. (2015). P058 Comparison of EndoPredict and MammaPrint in hormone receptor positive, HER2 negative breast cancer. The Breast. 24. S46–S47. 1 indexed citations

Dirschmid, K, William Sterlacci, Frank Oellig, et al.. (2012). Absence of extramural venous invasion is an excellent predictor of metastasis-free survival in colorectal carcinoma stage II—a study using tangential tissue sectioning. Journal of Clinical Pathology. 65(7). 619–623. 11 indexed citations

Jasarevic, Zerina, et al.. (2011). Recurrent cranial fibroblastic neoplasm in a male adolescent: Case report and review of the literature. Journal of Plastic Reconstructive & Aesthetic Surgery. 64(7). 949–951. 3 indexed citations

Bagó-Horváth, Zsuzsanna, Margaretha Rudas, Peter Dubsky, et al.. (2011). Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer. Clinical Cancer Research. 17(24). 7828–7834. 13 indexed citations

10.

Lax, Sigurd, et al.. (2011). P5-11-15: Should HER-2 Score 0/1+ Breast Cancer Cases Be Retested by In-Situ Hybridisation? Results of a Multicenter Retesting Study.. Cancer Research. 71(24_Supplement). P5–11. 1 indexed citations

11.

Knauer, Michael, et al.. (2011). Intraoperative ultrasound for improvement of re-excision rates in breast-conserving surgery.. Journal of Clinical Oncology. 29(27_suppl). 91–91. 1 indexed citations

12.

Knauer, Michael, A. Haid, Roswitha Köberle-Wührer, et al.. (2008). Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer. European Journal of Surgical Oncology. 35(8). 798–804. 4 indexed citations

13.

Haid, A., Michael Knauer, Zerina Jasarevic, et al.. (2007). Intra-operative Sonography: A Valuable Aid During Breast-Conserving Surgery for Occult Breast Cancer. Annals of Surgical Oncology. 14(11). 3090–3101. 63 indexed citations

14.

Knauer, Michael, A. Haid, Zerina Jasarevic, et al.. (2007). Intraoperative sonography: a valuable diagnostic tool in the surgeon's hand for the operation of non-palpable breast lesions. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 4(3). 1 indexed citations

15.

Comuzzi, Barbara, Stefan Schmidt, Zerina Jasarevic, et al.. (2004). The androgen receptor co‐activator CBP is up‐regulated following androgen withdrawal and is highly expressed in advanced prostate cancer. The Journal of Pathology. 204(2). 159–166. 78 indexed citations

16.

Kaser, Arthur, Othmar Ludwiczek, Sandra Holzmann, et al.. (2004). Increased Expression of CCL20 in Human Inflammatory Bowel Disease. Journal of Clinical Immunology. 24(1). 74–85. 164 indexed citations

17.

Haid, A., et al.. (2003). Klinische Wertigkeit und zuk�nftige Aspekte der "Sentinel Node Biopsy" beim Mammakarzinom. Der Chirurg. 74(7). 657–664. 10 indexed citations

18.

Haid, A., Roswitha Köberle-Wührer, Michael Knauer, et al.. (2002). Morbidity of Breast Cancer Patients Following Complete Axillary Dissection or Sentinel Node Biopsy Only: A Comparative Evaluation. Breast Cancer Research and Treatment. 73(1). 31–36. 112 indexed citations

19.

Rhomberg, W., et al.. (2000). Aggressive Angiomyxoma: Irradiation for Recurrent Disease. Strahlentherapie und Onkologie. 176(7). 324–326. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact